New Delhi, May 15 (PTI) Mankind Pharma on Wednesday said its consolidated profit after tax increased 62 per cent to Rs 477 crore in the March quarter.

The drug maker had reported a profit after tax (PAT) of Rs 294 crore for the January-March period of FY23.

Also Read | Sukhdev Thapar Birth Anniversary 2024: Netizens Pay Tributes to Indian Freedom Fighter by Sharing Photos, Wallpapers and Quotes Online.

Revenue from operations rose to Rs 2,441 crore in the period under review from Rs 2,053 crore in the year-ago period, Mankind Pharma said in a statement.

For the year ended March 31, 2024, the company reported a PAT of Rs 1,942 crore, up 48 per cent from Rs 1,310 crore in FY23.

Also Read | Mobile Verification Scam: Government Warns Against Fraudsters Threatening to Disconnect Mobile Number by Posing as TRAI Officials, Asks Citizens to Report Fraud Calls on sancharsaathi.gov.in.

Revenue from operations rose to Rs 10,335 crore in FY24 as against Rs 8,749 crore in FY23.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)